During the past decade, Strasbourg Oncologie Médicale conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Strasbourg Oncologie Médicale" #1 collaborator was "Amgen" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "HOVON - Dutch Haemato-Oncology Association" with 1 trials as a collaborator, "Janssen Research & Development, LLC" with 1 trials as a collaborator and "Sanofi" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Strasbourg Oncologie Médicale" are "Multiple Myeloma" (2 trials). Many other conditions were trialed in "Strasbourg Oncologie Médicale" in a lesser frequency.

Most popular intervention types in "Strasbourg Oncologie Médicale" are "Drug" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "ASCT" (1 trials), "Bortezomib (VELCADE), Thalidomide, and Dexamethasone (VTD)" (1 trials), "Bortezomib, Thalidomide, Dexamethasone (VTD) + daratumumab" (1 trials), "Daratumumab" (1 trials) and "Isatuximab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Strasbourg Oncologie Médicale" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Strasbourg Oncologie Médicale". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Strasbourg Oncologie Médicale, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Strasbourg Oncologie Médicale, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".